Efficacy and Safety of Lucitanib in Advanced Thymic Carcinoma: A Randomized Phase II Trial.
Overview & Synopsis
Open access biomedical research article published in MedComm (2020).
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Efficacy and Safety of Lucitanib in Advanced Thymic Carcinoma: A Randomized Phase II Trial. |
|---|---|
| Author / Organization | Fang W, Zhou C, Wang C, Wu K, Fu J, Lin X, Zhang H, Chen J, Zhang P, Zhang Y, Tang P, Zheng Y, Liu Y, Zhi X, Gao Z, Fan Q, Cai H, Li F, Guo X, Zhang B, Mu R, Yu Z |
| Subject & Discipline | MedComm (2020) |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-3711 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |